Joann Ford
Psychiatric/Mental Health · Tampa, FLNPI 1689140170
Payments from drug & device makers
Across 239 payments — averaging $24.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Teva Pharmaceuticals USA, Inc.$932
- AbbVie$708
- Alkermes, Inc.$625
- Neurocrine Biosciences, Inc.$519
- E.r. Squibb & Sons, L.L.C.$449
- plus $1K from 11 others
What the payments were for
- Food & beverage$5,86398%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$471
- INVEGA SUSTENNA$424
- ABILIFY MAINTENA$268
- ABILIFY ASIMTUFII$268
- COBENFY$251
- Austedo XR$230
- INVEGA TRINZA$146
- INGREZZA$133
- SPRAVATO$125
- UZEDY$121
- VRAYLAR$103
How this compares
$5,963 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 68 | $200,587 |
| AustedoDeutetrabenazine | 18 | $97,407 |
| AristadaAripiprazole Lauroxil | 21 | $57,554 |
| Clozapine | 69 | $4,533 |
| Haloperidol Decanoate | 47 | $3,817 |
| Haloperidol | 87 | $2,505 |
| Divalproex Sodium ErDivalproex Sodium | 50 | $2,037 |
| Divalproex Sodium | 101 | $1,924 |
| Benztropine Mesylate | 121 | $1,850 |
| Atomoxetine Hcl | 14 | $1,727 |
| Olanzapine | 64 | $1,071 |
| Olanzapine OdtOlanzapine | 13 | $1,011 |
| Hydroxyzine Pamoate | 53 | $862 |
| Buspirone Hcl | 51 | $782 |
| Risperidone | 43 | $581 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $1,628 | $200,58768 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $932 | $97,40718 claims |
| Alkermes, Inc.Aristada | $625 | $57,55421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Tampa
- Cheedy JajaTampa$266K
- Tonya King-CharltonTampa$31K
- Michele CreamerTampa$18K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.